28 December 2010
Acute myopia and angle closure glaucoma associated with topiramate use: A case series
AliReza Dehghani, Leila Rezaei, AliReza PeymanDOI: 10.12659/AJCR.881366
Am J Case Rep 2010; 11:241-243
Abstract
Abstract
Background: To report 7 cases of topiramate-induced angle closure glaucoma.
Case Report: We present 7 cases of angle closure glaucoma after topiramate administration for neuropsychological disorders. All patients were female. The average age of patients was 33.28 years (ranging from 19 to 44 years). The mean interval between drug administration and symptoms onset was 12.2 days (ranging from 4 to 30 days).The mean best corrected visual acuity was 3 meters counting fingers in both eyes. The mean refractive errors was –6.50 diopters (ranging from –3.00 to –12.00 diopters). The mean intraocular pressure was 44.71 mmHg (ranging from 34 to 60 mmHg). The mean normalization time of intraocular pressure was 12.30 hours (ranging from 8 to 23 hours).
Conclusions: Acute myopia and acute angle closure glaucoma are serious adverse effects of topiramate use, both of which are reversible with immediate discontinuation of the drug. Thus, obtaining the drug history of the patients is critical in evaluation of angle closure glaucoma.
Keywords: Topiramat, angle closure, Glaucoma
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947597
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948156
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948795
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947300
Most Viewed Current Articles
21 Jun 2024 : Case report
100,609
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,868
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,615
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,134
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200